Implementing Biosecurity On Nursery-Grow-Finish Sites: A podcast

Thank you for your interest in this archived blog post. The link below may not work anymore, but you can access older episodes of “At the Meeting” at the podcast’s website!

Dr. Tyler Te Grotenhuis (Christensen Farms) and Dr. Mike Eisenmenger (recently retired from the Swine Vet Center) discuss with the At The Meeting team how to implement biosecurity on nursery-grow-finish sites.

Best of Leman 2022: Lauren Glowzenski – Actinobacillus pleuropneumoniae outbreak in an Iowa Finisher

This is our most popular series on the blog. Once a month, we are sharing with you a presentation given at the Allen D. Leman swine conference, on topics that the swine group found interesting, innovative or that lead to great discussions.

Want more? Find previous presentations in our Best of Leman archives.

Dr. Lauren Glowzenski from TriOak Foods, gave this talk on the impact of biosecurity related to an App case, during the Carlos Pijoan SDEC symposium, a pre-conference workshop offered annually at the Leman Swine Conference.

Evaluating the economic impact of an autogenous influenza vaccine in the finishing phase with a pre-post analysis utilizing closeout data

This is our Friday rubric: every week a new Science Page from the Bob Morrison’s Swine Health Monitoring Project. The previous editions of the science page are available on our website.

In today’s Science Page Kaci Way, Jessica Higgins, Todd Wolff, Derald Holtkamp and Lynette Holeman share the results of a study evaluating the benefit of influenza vaccines in finishing pigs.

Phase-Feeding: Do Fewer Phases Compromise Growth Performance in Grow-Finish?

This is our Friday rubric: every week a new Science Page from the Bob Morrison’s Swine Health Monitoring Project. The previous editions of the science page are available on our website.

This week, Dr. Mariana Menegat for Kansas State Univeristy shares her latest results when evaluating the optimal number of phases in feeding growing pigs.

Key Points

Fewer dietary phases, i.e. from 4 to 3 or 2 phases, with lysine levels set close to the requirements does not compromise growth performance of grow-finish pigs.

Antimicrobial use in wean to market pigs in the United States

Today, we are sharing a publication from Drs. Davies and Singer regarding antimicrobial use in wean-to-market pigs in the United States based on self-reported data from swine producers and veterinarians. This work is published in Zoonoses and Public Health in open access.

Impacts

Demonstrates the feasibility of obtaining data on antimicrobial use in the United States swine industry through sharing of proprietary records within industry.
Provides the first substantial description of antimicrobial use in United States swine beyond annual sales and distribution data.
Indicates that specific metrics of antibiotic use that focus on conditions within individual industries will be most useful to advance stewardship.